EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-H.
Right arrow Articles by Shin, T.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-H.
Right arrow Articles by Shin, T.-Y.
Experimental Biology and Medicine 233:192-199 (2008)
doi: 10.3181/0708-RM-222
© 2008 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Antiallergic Effects of Vitis amurensis on Mast Cell–Mediated Allergy Model

Sang-Hyun Kim*, Taeg Kyu Kwon{dagger} and Tae-Yong Shin{ddagger},1

* Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700–422, South Korea; {dagger} Department of Immunology and Chronic Disease Research Center and Institute for Medical Science, School of Medicine, Keimyung University, Taegu 700–712, South Korea; and {ddagger} College of Pharmacy, Woosuk University, Jeonju 565–701, South Korea

To whom requests for reprints should be addressed at 1 College of Pharmacy, Woosuk University, Jeonju 565–701, South Korea. E-mail: tyshin{at}woosuk.ac.kr

In this study, we investigated the effect of the methanol extract of fruits of Vitis amurensis Rupr. (Vitaceae; MEVA) on the mast cell–mediated allergy model and studied the possible mechanism of action. Mast cell–mediated allergic disease is involved in many diseases, such as asthma and sinusitis. The discovery of drugs for the treatment of allergic disease is an important subject in human health. MEVA inhibited compound 48/80–induced systemic reactions and serum histamine release in a dose-dependent manner in mice. MEVA decreased immunoglobulin E (IgE)–mediated local allergic reactions, passive cutaneous anaphylaxis. MEVA dose-dependently reduced histamine release from mast cells activated by compound 48/80 or IgE. The inhibitory effect of MEVA on histamine release was mediated by the modulation of intracellular calcium. In addition, MEVA attenuated the phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)–stimulated secretion of tumor necrosis factor-{alpha}, interleukin-6 (IL-6), and IL-8 in human mast cells. The inhibitory effect of MEVA on these proinflammatory cytokines was p38 mitogen-activated protein kinase and nuclear factor-{kappa}B (NF-{kappa}B) dependent. Our findings provide evidence that MEVA inhibits mast cell–derived, immediate-type allergic reactions and involvement of proinflammatory cytokines, p38 MAPK, and NF-{kappa}B in these effects.

Key Words: Vitis amurensis • allergic reaction • mast cells • histamine • proinflammatory cytokines







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Experimental Biology and Medicine.